Croop R - Search Results

1

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial.

Lipton RB, Croop R, Stock DA, Madonia J, Forshaw M, Lovegren M, Mosher L, Coric V, Goadsby PJ. Lipton RB, et al. Among authors: croop r. Lancet Neurol. 2023 Mar;22(3):209-217. doi: 10.1016/S1474-4422(22)00517-8. Lancet Neurol. 2023. PMID: 36804093 Clinical Trial.

2

Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305).

Powell LC, L'Italien G, Popoff E, Johnston K, O'Sullivan F, Harris L, Croop R, Coric V, Lipton RB. Powell LC, et al. Among authors: croop r. Adv Ther. 2023 Feb;40(2):585-600. doi: 10.1007/s12325-022-02369-x. Epub 2022 Nov 22. Adv Ther. 2023. PMID: 36417057 Free PMC article. Clinical Trial.

3

Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials.

Lipton RB, Blumenfeld A, Jensen CM, Croop R, Thiry A, L'Italien G, Morris BA, Coric V, Goadsby PJ. Lipton RB, et al. Among authors: croop r. Cephalalgia. 2023 Feb;43(2):3331024221141686. doi: 10.1177/03331024221141686. Cephalalgia. 2023. PMID: 36739511 Free article.

4

Rimegepant 75 mg in Subjects With Hepatic Impairment: Results of a Phase 1, Open-Label, Single-Dose, Parallel-Group Study.

Bhardwaj R, Ivans A, Stringfellow J, Morris B, Coric V, Croop R, Bertz R. Bhardwaj R, et al. Among authors: croop r. Clin Pharmacol Drug Dev. 2023 Aug;12(8):790-800. doi: 10.1002/cpdd.1244. Epub 2023 Apr 18. Clin Pharmacol Drug Dev. 2023. PMID: 37073443 Clinical Trial.

5

Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial.

Yu S, Kim BK, Guo A, Kim MH, Zhang M, Wang Z, Liu J, Moon HS, Tan G, Yang Q, McGrath D, Hanna M, Stock DA, Gao Y, Croop R, Lu Z. Yu S, et al. Among authors: croop r. Lancet Neurol. 2023 Jun;22(6):476-484. doi: 10.1016/S1474-4422(23)00126-6. Lancet Neurol. 2023. PMID: 37210098 Clinical Trial.

6

A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants.

Bertz R, Bhardwaj R, Morris BA, Ashbrenner E, Coric V, Croop R. Bertz R, et al. Among authors: croop r. Cephalalgia. 2023 Jun;43(6):3331024231179131. doi: 10.1177/03331024231179131. Cephalalgia. 2023. PMID: 37282507 Free article. Clinical Trial.

7

Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adults.

Croop R, Bhardwaj R, Anderson MS, Matschke KT, Hould J, Bertz R, Liu J, Lipton RB. Croop R, et al. Cephalalgia. 2024 Feb;44(2):3331024231219505. doi: 10.1177/03331024231219505. Cephalalgia. 2024. PMID: 38366390 Free article. Clinical Trial.

8

The Pharmacokinetics, Safety, and Tolerability of Rimegepant 75 mg Are Similar in Elderly and Nonelderly Adults: A Phase 1, Open-Label, Parallel-Group, Single-Dose Study.

Bhardwaj R, Morris B, Bertz R, Croop R, Liu J. Bhardwaj R, et al. Among authors: croop r. Clin Pharmacol Drug Dev. 2024 Jan;13(1):37-44. doi: 10.1002/cpdd.1337. Epub 2023 Oct 30. Clin Pharmacol Drug Dev. 2024. PMID: 37904724 Clinical Trial.

9

A Drug-Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2- and MATE1-Mediated Transport of Metformin in Healthy Participants.

Bhardwaj R, Morris B, Matschke K, Bertz R, Croop R, Liu J. Bhardwaj R, et al. Among authors: croop r. Clin Pharmacol Drug Dev. 2024 May;13(5):465-473. doi: 10.1002/cpdd.1352. Epub 2024 Jan 4. Clin Pharmacol Drug Dev. 2024. PMID: 38174905 Clinical Trial.

10

Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants.

Bhardwaj R, Stringfellow JC, Morris B, Croop RS, Bertz RJ. Bhardwaj R, et al. Among authors: croop rs. Headache. 2023 May;63(5):652-662. doi: 10.1111/head.14512. Epub 2023 May 4. Headache. 2023. PMID: 37140071 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page